Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis.

Autor: Vuckovic BA; Faculty of Medicine, Center of Laboratory Medicine, University of Novi Sad, Novi Sad., Djeric MJ; Faculty of Medicine, Center of Laboratory Medicine, University of Novi Sad, Novi Sad., Tomic BV; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade., Djordjevic VJ; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade., Bajkin BV; Dental Clinic of Vojvodina, Faculty of Medicine Novi Sad, University of Novi Sad, Novi Sad, Serbia., Mitic GP; Faculty of Medicine, Center of Laboratory Medicine, University of Novi Sad, Novi Sad.

Publikováno v: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Jan; Vol. 29 (1), pp. 19-24.